Mechelen, Belgium - October 01, 2024 –
Nipro, a global leader in healthcare and drug delivery systems, today announced a new collaboration with Corning Incorporated (NYSE: GLW), one of the world’s top innovators in materials science. This collaboration combines Nipro’s high-quality glass vials with Corning’s cutting-edge Velocity® Vial coating technology, helping advance the pharmaceutical packaging industry.
Velocity® Vials, made of Type I borosilicate glass, feature a proprietary low-friction coating that improves filling-line efficiency by 20% to 50%, significantly reducing the total cost of ownership for pharmaceutical companies. The coating technology also minimizes damage that leads to glass particulates, cracks, breaks, and cosmetic defects.
Key Benefits of Corning® Velocity® Vial Technology:
- Improved Efficiency:
Velocity® Vials’ coating reduces friction on fill-finish lines, enhancing production efficiency by up to 50%. - Minimized Glass Damage:
The technology reduces the likelihood of particulate generation, breakages, and cosmetic rejects. - Cost Efficiency:
By increasing line efficiency, Velocity® Vials lower the total cost of ownership for pharmaceutical companies.
Quote Nipro
“We are thrilled to embark on this collaboration that merges Nipro's unmatched vial expertise with Corning’s cutting-edge Velocity® Vial coating technology. This will allow us to offer innovative packaging solutions that help our customers optimize their filling-line performance while maintaining the highest quality standards,” said Stephan Arnold, CEO of Nipro PharmaPackaging International.
Quote Corning
"We have witnessed the impact of Corning® Velocity® Vials in improving pharmaceutical manufacturing performance and quality. Now, we are excited to announce our collaboration with Nipro to expand the availability of Velocity® Vials, globally. This collaboration will provide customers with direct access from Nipro, an important step in expanding customer access." - Brendan Mosher, VP & GM, Corning Life Sciences.”
The collaboration aims to bring significant benefits to the pharmaceutical industry, accelerating the delivery of life-saving drugs and treatments to the market.
Contact Nipro
Annick Somers - Chief Marketing Officer | Marketing & PR - General
Contact Corning Incorporated
Vanessa Baca - Marketing Communications Account Manager, +1-339-222-9899, [email protected]
About Nipro
Nipro PharmaPackaging is specialized in developing and manufacturing advanced pharma packaging products and complete packaging solutions for early development drugs or the enhancement of packaging solutions for existing drugs.
Nipro PharmaPackaging is part of Nipro Corporation Japan, established in 1954. As a leading global healthcare company with over 38,000+ employees worldwide, Nipro (www.nipro-group.com) serves the Medical Device, Pharmaceutical, Regenerative Medicine and Pharmaceutical Packaging industries.
About Corning Incorporated
Corning (www.corning.com) is one of the world's leading innovators in materials science, with a 170-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramic science, and optical physics along with its deep manufacturing and engineering capabilities to develop category-defining products that transform industries and enhance people's lives. Corning succeeds through sustained investment in RD&E, a unique combination of material and process innovation, and deep, trust-based relationships with customers who are global leaders in their industries. Corning's capabilities are versatile and synergistic, which allows the company to evolve to meet changing market needs, while also helping its customers capture new opportunities in dynamic industries. Today, Corning's markets include optical communications, mobile consumer electronics, display, automotive, solar, semiconductors, and life sciences.
